Joan Maurel

Sobre mi

Publicacions destacades

• Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD1402 Trial

  Autors:

  Vidal, Joana; Casadevall, David; Bellosillo, Beatriz; Pericay, Carles; Garcia-Carbonero, Rocio;

  (...)

  Maurel, Joan; Faull, Iris; Raymond, Victoria; Fernandez-Martos, Carlos; Montagut, Clara.

  Veure llistat complet d'autors

  Referència: Clinical Cancer Research 2021.

• Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

  Autors:

  Tempero, M; Fong, L; Oh, DY; Tabernero, J; Macarulla, T;

  (...)

  Lonardi, S; Coussens, LM; Tsao, LC; Cole, G; James, D.

  Veure llistat complet d'autors

  Referència: Annals Of Oncology 2021.

• Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients

  Autors:

  Oliveres, H; Pesántez, D; Maurel, J;

  Referència: International Journal Of Molecular Sciences 2021.

• SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

  Autors:

  Gomez-Espana, Ma A; Montes, A F; Garcia-Carbonero, R; Mercade, T M; Maurel, J;

  Martin, A M; Pazo-Cid, R; Vera, R; Carrato, A; Feliu, J.

  Referència: Clinical & Translational Oncology 2021.

• Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?

  Autors:

  Rodriguez, A; Esposito, F; Oliveres, H; Maurel, J; Torres, F;

  Referència: Journal Of Clinical Medicine 2021.

• VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02)

  Autors:

  Feliu, Jaime; Garcia-Carbonero, Rocio; Capdevila, Jaume; Guasch, Inmaculada; Alonso-Orduna, Vicente;

  (...)

  Lopez-Gomez, Miriam; Leon, Ana; Caro, Monica; Fernandez, Teresa; Maurel, Joan.

  Veure llistat complet d'autors

  Referència: Cancer Medicine 2020.

• MET inhibitors in cancer: pitfalls and challenges

  Autors:

  Oliveres, Helena; Pineda, Estela; Maurel, Joan;

  Referència: Expert Opinion On Investigational Drugs 2020.

• The Tumor Microenvironment in Colorectal Cancer Therapy

  Autors:

  Pedrosa, Leire; Esposito, Francis; Thomson, Timothy M; Maurel, Joan;

  Referència: Cancers 2019.

• RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy

  Autors:

  Alonso-Espinaco, Virginia; Cuatrecasas, Miriam; Alonso, Vicente; Escudero, Pilar; Marmol, Maribel;

  (...)

  Jares, Pedro; Castells, Antoni; Jose Lozano, Juan; Rosell, Rafael; Maurel, Joan.

  Veure llistat complet d'autors

  Referència: European Journal Of Cancer 2014.

• Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer

  Autors:

  Gallego, Rosa; Codony-Servat, Jordi; Garcia-Albeniz, Xabier; Carcereny, Enric; Longaron, Raquel;

  Oliveras, Angeles; Tosca, Monica; Maria Auge, Josep; Gascon, Pedro; Maurel, Joan.

  Referència: Endocrine-Related Cancer 2009.